275 related articles for article (PubMed ID: 31687863)
1. Beyond tumor mutational burden: potential and limitations in using exosomes to predict response to immunotherapy.
Crow J; Samuel G; Godwin AK
Expert Rev Mol Diagn; 2019 Dec; 19(12):1079-1088. PubMed ID: 31687863
[No Abstract] [Full Text] [Related]
2. The potential of tumor-derived exosomes for noninvasive cancer monitoring: an update.
Whiteside TL
Expert Rev Mol Diagn; 2018 Dec; 18(12):1029-1040. PubMed ID: 30406709
[No Abstract] [Full Text] [Related]
3. Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities.
Salehi M; Sharifi M
J Cell Physiol; 2018 Sep; 233(9):6370-6380. PubMed ID: 29323722
[TBL] [Abstract][Full Text] [Related]
4. REMEDIAL APPLICATIONS OF EXOSOMES IN CANCER, INFECTIONS AND DIABETES.
Wang Q; Ding X; Zhen F; Ma J; Meng F
Acta Pol Pharm; 2017 Mar; 74(2):313-320. PubMed ID: 29624236
[TBL] [Abstract][Full Text] [Related]
5. The role of exosomal PD-L1 in tumor progression and immunotherapy.
Xie F; Xu M; Lu J; Mao L; Wang S
Mol Cancer; 2019 Oct; 18(1):146. PubMed ID: 31647023
[TBL] [Abstract][Full Text] [Related]
6. Emerging MS-based platforms for the characterization of tumor-derived exosomes isolated from human biofluids: challenges and promises of MudPIT.
Ferrari E; De Palma A; Mauri P
Expert Rev Proteomics; 2017 Sep; 14(9):757-767. PubMed ID: 28780902
[TBL] [Abstract][Full Text] [Related]
7. Techniques Associated with Exosome Isolation for Biomarker Development: Liquid Biopsies for Ovarian Cancer Detection.
Sharma S; Salomon C
Methods Mol Biol; 2020; 2055():181-199. PubMed ID: 31502152
[TBL] [Abstract][Full Text] [Related]
8. Exosomal non-coding RNAs: a promising cancer biomarker.
Yang H; Fu H; Xu W; Zhang X
Clin Chem Lab Med; 2016 Dec; 54(12):1871-1879. PubMed ID: 27166723
[TBL] [Abstract][Full Text] [Related]
9. Exosomes for Non-Invasive Cancer Monitoring.
Kalishwaralal K; Kwon WY; Park KS
Biotechnol J; 2019 Jan; 14(1):e1800430. PubMed ID: 30358137
[TBL] [Abstract][Full Text] [Related]
10. The potential role of tumor-derived exosomes in diagnosis, prognosis, and response to therapy in cancer.
Czystowska-Kuzmicz M; Whiteside TL
Expert Opin Biol Ther; 2021 Feb; 21(2):241-258. PubMed ID: 32813990
[TBL] [Abstract][Full Text] [Related]
11. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.
Castillo J; Bernard V; San Lucas FA; Allenson K; Capello M; Kim DU; Gascoyne P; Mulu FC; Stephens BM; Huang J; Wang H; Momin AA; Jacamo RO; Katz M; Wolff R; Javle M; Varadhachary G; Wistuba II; Hanash S; Maitra A; Alvarez H
Ann Oncol; 2018 Jan; 29(1):223-229. PubMed ID: 29045505
[TBL] [Abstract][Full Text] [Related]
12. The role of exosomes in liquid biopsy for cancer diagnosis and prognosis prediction.
Li S; Yi M; Dong B; Tan X; Luo S; Wu K
Int J Cancer; 2021 Jun; 148(11):2640-2651. PubMed ID: 33180334
[TBL] [Abstract][Full Text] [Related]
13. Exosomal biomarkers for cancer diagnosis and patient monitoring.
Makler A; Asghar W
Expert Rev Mol Diagn; 2020 Apr; 20(4):387-400. PubMed ID: 32067543
[No Abstract] [Full Text] [Related]
14. Extracellular vesicles in ovarian cancer: applications to tumor biology, immunotherapy and biomarker discovery.
Nawaz M; Fatima F; Nazarenko I; Ekström K; Murtaza I; Anees M; Sultan A; Neder L; Camussi G; Valadi H; Squire JA; Kislinger T
Expert Rev Proteomics; 2016; 13(4):395-409. PubMed ID: 26973172
[TBL] [Abstract][Full Text] [Related]
15. Exosomal proteins as potential markers of tumor diagnosis.
Li A; Zhang T; Zheng M; Liu Y; Chen Z
J Hematol Oncol; 2017 Dec; 10(1):175. PubMed ID: 29282096
[TBL] [Abstract][Full Text] [Related]
16. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
Valentino A; Reclusa P; Sirera R; Giallombardo M; Camps C; Pauwels P; Crispi S; Rolfo C
Clin Transl Oncol; 2017 Jun; 19(6):651-657. PubMed ID: 28054319
[TBL] [Abstract][Full Text] [Related]
17. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.
Syn NL; Yong WP; Goh BC; Lee SC
Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):911-22. PubMed ID: 27249175
[TBL] [Abstract][Full Text] [Related]
18. Exosomes as a Multicomponent Biomarker Platform in Cancer.
LeBleu VS; Kalluri R
Trends Cancer; 2020 Sep; 6(9):767-774. PubMed ID: 32307267
[TBL] [Abstract][Full Text] [Related]
19. The Biological Function and Therapeutic Potential of Exosomes in Cancer: Exosomes as Efficient Nanocommunicators for Cancer Therapy.
Choi JU; Park IK; Lee YK; Hwang SR
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33028046
[TBL] [Abstract][Full Text] [Related]
20. Isolation of circulating exosomes and identification of exosomal PD-L1 for predicting immunotherapy response.
Zhang J; Zhu Y; Guan M; Liu Y; Lv M; Zhang C; Zhang H; Zhang Z
Nanoscale; 2022 Jun; 14(25):8995-9003. PubMed ID: 35700522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
